TGFB1 and hepatocellular carcinoma: Our results highlight the heterogeneity of HCC cell lines in response to TGF-β, but allowed identification and characterization of two general groups - one being responsive the other being insensitive to TGF-β-induced cytostatic program (i.e. inhibition of proliferation and/or induction of cell death).